All Peptide

ACE-031 is a recombinant peptide designed to inhibit myostatin, a regulatory protein that limits muscle growth. It acts by binding to myostatin and preventing its interaction with the activin receptor type II. ACE-031 has been primarily investigated in preclinical and experimental studies focused on muscle physiology, bone health, and metabolic balance.

Adipotide (also known as FTPP) is a synthetic peptide investigated for its ability to selectively affect blood vessels that supply white adipose tissue. Through its mechanism of targeting prohibitin receptors on fat-associated vasculature, Adipotide has been studied in preclinical research for its potential to influence fat tissue biology and related metabolic pathways.

AOD-9604 is a synthetic peptide fragment derived from the C-terminal end of human growth hormone (HGH), corresponding to amino acids 176–191. It has been investigated in research settings for its role in stimulating fat metabolism and promoting lipolysis while not influencing blood sugar or IGF-1 levels. AOD9604 continues to be of interest in studies focusing on metabolic modulation and body composition research.

AOD-9604 is a synthetic peptide fragment derived from the C-terminal end of human growth hormone (HGH), corresponding to amino acids 176–191. It has been investigated in research settings for its role in stimulating fat metabolism and promoting lipolysis while not influencing blood sugar or IGF-1 levels. AOD9604 continues to be of interest in studies focusing on metabolic modulation and body composition research.

ARA290 (also known as Cibinetide or pHBSP) is a synthetic peptide derived from erythropoietin (EPO). It was designed to preserve tissue-protective and anti-inflammatory properties of EPO without stimulating red blood cell production. ARA290 primarily interacts with the innate repair receptor (IRR), which is upregulated during tissue stress or injury. Research has explored its potential roles in neuroprotection, inflammation control, and tissue repair.

BPC-157 (Body Protective Compound-157) is a synthetic peptide fragment consisting of 15 amino acids, derived from a protein found in human gastric juice. It has been investigated in preclinical and experimental studies for its potential role in tissue repair, angiogenesis, and inflammation regulation. Research interest spans musculoskeletal models, gastrointestinal systems, vascular biology, and neurological pathways.

BPC-157 (Body Protective Compound-157) is a synthetic peptide fragment consisting of 15 amino acids, derived from a protein found in human gastric juice. It has been investigated in preclinical and experimental studies for its potential role in tissue repair, angiogenesis, and inflammation regulation. Research interest spans musculoskeletal models, gastrointestinal systems, vascular biology, and neurological pathways.

BPC-157 (Body Protective Compound-157) is a synthetic peptide fragment consisting of 15 amino acids, derived from a protein found in human gastric juice. It has been investigated in preclinical and experimental studies for its potential role in tissue repair, angiogenesis, and inflammation regulation. Research interest spans musculoskeletal models, gastrointestinal systems, vascular biology, and neurological pathways.

Cagrilintide is a synthetic peptide designed as a long-acting amylin analog. Amylin is a hormone co-secreted with insulin in the pancreas that contributes to satiety, gastric emptying, and postprandial glucose regulation. Cagrilintide has been studied in preclinical and clinical research for its potential role in metabolic regulation, appetite signaling, and energy balance.

CJC-1295 without DAC, also called Modified GRF (1-29), is a synthetic growth hormone–releasing hormone (GHRH) analog composed of 30 amino acids. It was designed to provide improved stability compared to native GHRH while maintaining a short-acting profile. Unlike its DAC-linked counterpart, it has a relatively brief half-life and has been studied in research settings for its ability to stimulate pulsatile growth hormone (GH) release.

Dermorphin is a naturally occurring opioid peptide originally isolated from the skin of the South American frog Phyllomedusa sauvagii. It has attracted significant research interest due to its high affinity for μ-opioid receptors (MORs) and unique structural properties that distinguish it from classical opioid compounds. Dermorphin continues to serve as a valuable tool in neuropharmacology and receptor biology research

DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring nonapeptide (9 amino acids) that was originally isolated from the hypothalamus. It has been investigated in neuroscience and sleep physiology research for its association with delta-wave activity during deep sleep. Studies suggest DSIP may play a role in regulating sleep cycles, stress responses, and neuroendocrine balance, although its exact endogenous function is still under active investigation